LEP and myeloid sarcoma: In summary, although several studies have found increased leptin levels in MS patients, signaling the hormone could somehow influence burden of disease, it is also important to note they are not strictly comparable, as many did not include important variables affecting the outcome (BMI, gender, or use of DMTs).